Levi & Korsinsky, LLP Announces Investigation of Kayak Software Corporation (KYAK) and JDA Software Group Inc. (JDAS) and Class

 Levi & Korsinsky, LLP Announces Investigation of Kayak Software Corporation
 (KYAK) and JDA Software Group Inc. (JDAS) and Class Action Against Questcor
   Pharmaceuticals, Inc. (QCOR) and Peregrine Pharmaceuticals, Inc. (PPHM)

PR Newswire

NEW YORK, Nov. 20, 2012

NEW YORK, Nov. 20, 2012 /PRNewswire/ --

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)

Kayak Software Corporation
Levi & Korsinsky is investigating the Board of Directors of Kayak Software
Corporation (NasdaqGS: KYAK) for possible breaches of fiduciary duty and other
violations of state law in connection with the sale of the Company to
priceline.com Incorporated (NasdaqGS: PCLN) under which shareholders would
receive cash and stock valued at approximately $40 per share.

Click here to learn more about the investigation:
http://zlk.9nl.com/kayak-software-kyak, or call: 877-363-5972.

JDA Software Group Inc.
Levi & Korsinsky is investigating the Board of Directors of JDA Software Group
Inc. (NasdaqGS: JDAS) for possible breaches of fiduciary duty and other
violations of state law in connection with the sale of the Company to
RedPrairie Corp. for $45 per share.

Click here to learn more about the investigation
http://zlk.9nl.com/jda-software, or call: 877-363-5972.

Questcor Pharmaceuticals, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in
the USDC for the Central District of California on behalf of investors who
acquired Questcor Pharmaceuticals, Inc. (NasdaqGS: QCOR) securities between
April 26, 2011 and September 21, 2012.

For more information, click here:
http://zlk.9nl.com/questcor-pharmaceuticals-qcor. You have until November 26,
2012  to request that the Court appoint you as lead plaintiff. 

Peregrine Pharmaceuticals, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in
the USDC for the Central District of California on behalf of investors who
acquired Peregrine Pharmaceuticals, Inc. (NasdaqCM: PPHM) securities between
August 30, 2012 and September 26, 2012.

For more information, click here:
http://zlk.9nl.com/peregrine-pharmaceuticals-pphm. You have until November
27, 2012  to request that the Court appoint you as lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York and Washington
D.C. The firm has extensive expertise in prosecuting securities litigation
involving financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. Attorney advertising. Prior results do
not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP

Website: http://www.zlk.com
 
Press spacebar to pause and continue. Press esc to stop.